ZTS:NYSE
Zoetis Inc
$69.10
arrow_downward
-1.07%(-0.75) 1D
$69.17
arrow_upward
+0.10% (+0.070)todayPre-market
Closed: Oct 1, 4:03:52 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZTS...
Open
$70.00
High
$70.90
Low
$68.92
Mkt. cap
28.55B
Avg. vol.
4.54M
Volume
2.58K
Dividend
3.07%
Quarterly dividend
$0.53
Ex-dividend date
Jul 20, 2026
P/E ratio
11.37
52-wk high
$148.79
52-wk low
$68.92
EPS
$6.08
Beta
0.73
Shares outstanding
413.22M
No. of employees
14K
Open
$70.00
High
$70.90
Low
$68.92
Mkt. cap
28.55B
Avg. vol.
4.54M
Volume
2.58K
Dividend
3.07%
Quarterly dividend
$0.53
Ex-dividend date
Jul 20, 2026
P/E ratio
11.37
52-wk high
$148.79
52-wk low
$68.92
EPS
$6.08
Beta
0.73
Shares outstanding
413.22M
No. of employees
14K
News stories
From web sources and news partners
Insider Monkey
·
8 hours ago
Zoetis (ZTS) Has a Huge Animal Health Moat. Is It Starting to Crack?
Zacks
·
12 hours ago
Zoetis (ZTS) Stock Sinks As Market Gains: Here's Why
Yahoo Finance
·
13 hours ago
Zoetis (ZTS) Stock Sinks As Market Gains: Here's Why
Quiver Quantitative
·
20 hours ago
Fund Update: 1,398,638 ZOETIS (ZTS) shares added to CONFLUENCE INVESTMENT MANAGEMENT LLC portfolio
Profile
Zoetis Inc., headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries.
In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock. In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses. Wikipedia
About Zoetis Inc
CEOKristin C. Peck
Employees14.5K
Founded1952
HeadquartersParsippany-Troy Hills, New Jersey, United States
SectorPharmaceutical industry
Websitezoetis.com